Pfizer AG - Talzenna 0.5 mg, Hartkapseln | | 67141 | | 05 | | Talzenna 0.5 mg | | Hartkapseln | | L01XK04 | | Talazoparib | | 12.07.2024 | | |
| Composition | talazoparibum 0.5 mg ut talazoparibi tosilas, cellulosum microcristallinum silicificatum, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172 (nigrum), kalii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | Active Agent | Dose |
---|
Talazoparibum | 0.5 mg |
| BAG: Active Agent | Dose |
---|
Talazoparibum | 0.5 mg |
| | Inactive agents | | additional_information |
---|
(Nigrum) | | | (Rubrum) | | | Ammonii Hydroxidum | | | Cellulosum Microcristallinum Silicificatum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Pro Capsula | | | Propylenglycol | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
009 | 30 | 2646.97 | 2895.15 | A | SL | No |
|
|